We are live on ! Find out more
CF

C.T. Fitzpatrick Vulcan Value Partners

AUM $3.29B
1-Year Est. Return 6.08%
 

C.T. Fitzpatrick is the founder of Vulcan Value Partners, a firm that seeks high-quality businesses when they trade at discounts to estimated intrinsic value. Vulcan is known for a disciplined appraisal process and a willingness to hold cash when bargains are scarce. The firm’s equities strategies are widely followed in quality-value circles.

This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
-6.08%
3 Year Est. Return
+28.5%
5 Year Est. Return
+25.59%
10 Year Est. Return
+233.17%
AUM
$12.9B
AUM Growth
+$512M
Cap. Flow
+$279M
Cap. Flow %
2.16%
Top 10 Hldgs %
49.92%
Holding
59
New
7
Increased
23
Reduced
27
Closed
2

Top Buys

Rank Stock Value
1
KKR icon
KKR & Co
KKR
+$348M
2
UPS icon
United Parcel Service
UPS
+$326M
3
PH icon
Parker-Hannifin
PH
+$268M
4
AVGO icon
Broadcom
AVGO
+$227M
5
TER icon
Teradyne
TER
+$164M

Top Sells

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$281M
2
AZO icon
AutoZone
AZO
+$241M
3
AXTA icon
Axalta
AXTA
+$182M
4
ORLY icon
O'Reilly Automotive
ORLY
+$172M
5
ELV icon
Elevance Health
ELV
+$155M

Sector Composition

Rank Sector Weight
1 Financials 33.77%
2 Technology 23.63%
3 Healthcare 13.09%
4 Industrials 9.47%
5 Energy 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORCL icon
1
Oracle
ORCL
$422B
$1.1B 8.53%
25,019,520
+922,785
+4% +$42.5M
NOV icon
2
NOV
NOV
$7.28B
$880M 6.81%
20,274,296
-1,354,337
-6% -$54.8M
SWKS icon
3
Skyworks Solutions
SWKS
$10.1B
$636M 4.92%
6,581,779
+1,179,670
+22% +$115M
QRVO icon
4
Qorvo
QRVO
$8.43B
$625M 4.84%
7,798,102
+1,087,335
+16% +$84.1M
CVS icon
5
CVS Health
CVS
$119B
$613M 4.74%
9,522,744
+217,406
+2% +$14.3M
MA icon
6
Mastercard
MA
$509B
$561M 4.34%
2,853,374
-324,037
-10% -$60.9M
GOOG icon
7
Alphabet (Google) Class C
GOOG
$4.18T
$535M 4.14%
9,583,440
-165,020
-2% -$8.92M
V icon
8
Visa
V
$693B
$504M 3.9%
3,802,012
-644,706
-14% -$83M
MCK icon
9
McKesson
MCK
$100B
$503M 3.89%
3,768,099
+273,090
+8% +$39.9M
PH icon
10
Parker-Hannifin
PH
$126B
$495M 3.83%
3,178,193
+1,569,099
+98% +$268M
STT icon
11
State Street
STT
$51.4B
$461M 3.57%
4,952,036
+205,964
+4% +$20.4M
AXS icon
12
AXIS Capital
AXS
$7.2B
$433M 3.35%
7,781,689
-243,344
-3% -$13.9M
COR icon
13
Cencora
COR
$60.7B
$425M 3.29%
4,988,485
+82,224
+2% +$7.22M
BNY
14
Bank of New York Mellon
BNY
$108B
$424M 3.28%
7,871,202
+918,540
+13% +$50.7M
EG icon
15
Everest Group
EG
$14.2B
$422M 3.26%
1,830,722
+363,518
+25% +$85.3M
AET
16
DELISTED
Aetna Inc
AET
$393M 3.04%
2,142,029
-76,570
-3% -$13.6M
HLT icon
17
Hilton Worldwide
HLT
$73.5B
$389M 3.01%
4,914,914
+156,544
+3% +$12.7M
KKR icon
18
KKR & Co
KKR
$97.4B
$389M 3.01%
+15,643,574
New +$348M
UPS icon
19
United Parcel Service
UPS
$86.8B
$308M 2.38%
+2,899,895
New +$326M
META icon
20
Meta Platforms (Facebook)
META
$1.4T
$265M 2.05%
1,365,749
+667,502
+96% +$121M
NTRS icon
21
Northern Trust
NTRS
$33.6B
$260M 2.01%
2,522,199
+911,176
+57% +$96.5M
SPGI icon
22
S&P Global
SPGI
$127B
$232M 1.8%
1,139,734
-39,450
-3% -$7.79M
AVGO icon
23
Broadcom
AVGO
$1.75T
$225M 1.74%
+9,273,940
New +$227M
TER icon
24
Teradyne
TER
$58.7B
$160M 1.24%
+4,215,694
New +$164M
ELV icon
25
Elevance Health
ELV
$86.9B
$151M 1.17%
636,193
-667,468
-51% -$155M
1
2 3

Similar funds

BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
OCM
Oribel Capital Management New York $3.29B AUM 83.82% 1-Year Est. Return
CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
PCM
Prana Capital Management Greenwich, Connecticut $3.3B AUM 0.25% 1-Year Est. Return
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return
FB
Fulton Bank Lancaster, Pennsylvania $3.27B AUM 17.38% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

C.T. Fitzpatrick's Q2 2018 Portfolio in Review

As of Q2 2018, C.T. Fitzpatrick held 59 positions worth $12.9B, up 4.1% from $12.4B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

C.T. Fitzpatrick's Q2 2018 filing shows 7 new, 23 increased, 27 reduced and 2 closed positions. Its largest new stake was KKR & Co: 15,643,574 shares worth $389M. The largest sale was Cardinal Health, an estimated $281M.

By sector, the portfolio is most concentrated in Financials at 34% of assets, up from 33% a quarter earlier, followed by Technology and Healthcare.

  • C.T. Fitzpatrick's largest Q2 2018 buy was KKR & Co: 15,643,574 shares worth $389M.
  • C.T. Fitzpatrick added most to Parker-Hannifin in Q2 2018, an estimated $268M increase.
  • C.T. Fitzpatrick's biggest Q2 2018 reduction was Cardinal Health, cutting an estimated $281M.
  • C.T. Fitzpatrick fully exited RTX Corp in Q2 2018, selling an estimated $104M.
  • C.T. Fitzpatrick's ten largest holdings make up 50% of its $12.9B portfolio in Q2 2018.
  • C.T. Fitzpatrick opened 7 new positions and closed 2 in Q2 2018.
  • C.T. Fitzpatrick's portfolio value rose 4.1% quarter-over-quarter to $12.9B.

Based on Vulcan Value Partners's 13F filing for Q2 2018, filed 14 Aug 2018.